{{Rsnum
|rsid=180358
|Chromosome=11
|position=116728676
|Orientation=plus
|GMAF=0.1419
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 38.9 | 59.3
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 2.7 | 34.0 | 63.3
| ASW | 5.3 | 35.1 | 59.6
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 3.0 | 21.8 | 75.2
| LWK | 6.4 | 24.5 | 69.1
| MEX | 1.7 | 25.9 | 72.4
| MKK | 2.6 | 32.1 | 65.4
| TSI | 5.9 | 30.4 | 63.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs180358
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 11q23.3; Reported Gene(s): MGC13125; Risk Allele: rs180358-?); (p-value= 0.000006).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740728
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs180358
|overall_frequency_n=18
|overall_frequency_d=128
|overall_frequency=0.140625
|n_genomes=15
|n_genomes_annotated=0
|n_haplomes=15
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}